KIRA-7
KIRA-7, an imidazopyrazine compound, binds the IRE1α kinase (IC50 of 110 nM) to allosterically inhibit its RNase activity. KIRA-7 has an anti-fibrotic effect[1].
Product Specifications
CAS Number
[1937235-76-1]
UNSPSC
12352005
Target
IRE1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/kira-7.html
Concentration
10mM
Purity
99.09
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC(F)=C1)NC2=C3C=CC=CC3=C(C4=C5C(N)=NC=CN5C(C6(C)CC6)=N4)C=C2
Molecular Formula
C27H23FN6O
Molecular Weight
466.51
References & Citations
[1]Thamsen M, et al. Small molecule inhibition of IRE1α kinase/RNase has anti-fibrotic effects in the lung. PLoS One. 2019 Jan 9;14 (1) :e0209824.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Salmonella typhi Xanthine phosphoribosyltransferase (gpt)
Recombinant Salmonella typhi Xanthine phosphoribosyltransferase (gpt)
Recombinant Salmonella typhi Xanthine phosphoribosyltransferase (gpt)
Recombinant Salmonella typhi Xanthine phosphoribosyltransferase (gpt)
Recombinant Salmonella typhi Xanthine phosphoribosyltransferase (gpt)